Related Experiment Videos
Patterns of seminoma tissue markers and deletions
H Yamamoto1, U Rudén, E Ljungdahl-Ståhle
1Department of Virology, National Bacteriological Laboratory, Stockholm, Sweden.
International Journal of Cancer
|November 15, 1987
Summary
Seminomas exhibit significantly elevated placental alkaline phosphatase (PLAP)-like enzymes and altered levels of other tumor markers, distinct from placental tissue. These findings suggest enzyme defects contribute to seminoma development.
Area of Science:
- Oncology
- Biochemistry
- Tumor Marker Analysis
Background:
- Seminomas are germ cell tumors with specific biochemical profiles.
- Understanding tumor marker expression aids in diagnosis and understanding tumor biology.
Purpose of the Study:
- To analyze tumor marker expression in seminomas and compare it to normal and placental tissues.
- To investigate the role of placental alkaline phosphatase (PLAP)-like enzymes and other markers in seminoma.
Main Methods:
- Analysis of seminoma and control tissues for various tumor markers including PLAP-like enzymes, HCG, LAP, IAP, ferritin, CEA, AFP, and CA-50.
- Quantification of enzyme protein levels and specific enzymatic activity using monoclonal antibodies.
Main Results:
- All 18 seminomas showed very high PLAP-like enzyme levels, with significantly increased enzyme protein and half the specific activity compared to placenta.
- Elevated HCG was observed in 13/17 pure seminomas.
- Liver alkaline phosphatase (LAP) and intestinal alkaline phosphatase (IAP) were significantly increased in seminomas, with highest IAP in yolk-sac tumors.
Conclusions:
- Seminomas display a distinct tumor marker profile, characterized by elevated PLAP-like enzymes and altered CA-50 levels.
- Enzyme defects may underlie the observed changes in PLAP and CA-50 in seminomas.
- These findings contribute to the understanding of seminoma pathogenesis and potential diagnostic markers.